Cochrane · systematic review · CD006895

Probiotics for preventing acute upper respiratory tract infections

Zhao, Y, Dong, BR, Hao, Q · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

Acute Respiratory Infections2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 14.3%Low 4 · 57.1%Moderate 2 · 28.6%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections

Population: children, adults, and the elderly
7 questions
OutcomeEffectEvidenceStatus / GRADE
Number of participants who were diagnosed with acute URTIs: at least 1 event
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
RR 0.76 [0.67, 0.87]16 studies · 4798 participantsLow
Downgraded: risk of bias, publication bias
Number of participants who were diagnosed with acute URTIs: at least 3 events
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
RR 0.59 [0.38, 0.91]4 studies · 763 participantsModerate
Downgraded: risk of bias
Incidence rate of acute URTIs
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
Rate ratio 0.82 [0.73, 0.92]12 studies · 4364 participantsLow
Downgraded: risk of bias, publication bias
Mean duration of an episode of acute URTIs
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
no estimate extracted6 studies · 2406 participantsLow
Downgraded: risk of bias, inconsistency
Number of participants who were absent from childcare centre, school, or work due to acute URTIs
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
RR 0.14 [0.03, 0.59]1 study · 80 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Number of participants who used prescribed antibiotics for acute URTIs
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
RR 0.58 [0.42, 0.81]6 studies · 1548 participantsModerate
Downgraded: risk of bias
Number of participants who experienced at least 1 side effect or adverse event
Intention‐to‐treat analysis: probiotics vs placebo or no treatment
RR 1.02 [0.9, 1.15]8 studies · 2456 participantsLow
Downgraded: risk of bias, imprecision